A novel function of colony-stimulating factor 1 receptor in hTERT immortalization of human epithelial cells

Oncogene

Volumn 28, Issue 5, 2009, Pages 773-780

  Li, N F ^a   Kocher, H M ^a   Salako, M A ^a   Obermueller, E ^a   Sandle, J ^a   Balkwill, F ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Colony stimulating factor 1 receptor; HTERT; Human epithelial cells; Immortalization

Indexed keywords

COLONY STIMULATING FACTOR 1; MESSENGER RNA; MYC PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE INHIBITOR; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR RELA;

ARTICLE; AUTOCRINE EFFECT; CELL AGING; CELL CLONING; CELL COUNT; CELL IMMORTALIZATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTERNALIZATION; NORMAL HUMAN; NUCLEAR IMPORT; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; TELOMERASE; TRANSFECTION; UP-REGULATION;

EID: 59649094981     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.412     Document Type: Article

References (18)

1. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N et al. (2003). Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 63: 18-21.
2. Hahn WC. (2002). Immortalization and transformation of human cells. Mol Cells 13: 351-361.
3. Herbert BS, Gellert GC, Hochreiter A, Pongracz K, Wright WE, Zielinska D et al. (2005). Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition. Oncogene 24: 5262-5268.
4. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M et al. (1999). Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21: 111-114.
5. Kacinski BM, Carter D, Mittal K, Kohorn EI, Bloodgood RS, Donahue J et al. (1988). High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. Int J Radiat Oncol Biol Phys 15: 823-829.
6. Kacinski BM, Chambers SK, Stanley ER, Carter D, Tseng P, Scata KA et al. (1990). The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients. Int J Radiat Oncol Biol Phys 19: 619-626.
7. Kacinski BM, Stanley ER, Carter D, Chambers JT, Chambers SK, Kohorn EI et al. (1989). Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms. Int J Radiat Oncol Biol Phys 17: 159-164.
8. Li NF, Broad S, Lu YJ, Yang JS, Watson R, Hagemann T et al. (2007). Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression. Cell Prolif 40: 780-794.
9. Li NF, Wilbanks G, Balkwill F, Jacobs IJ, Dafou D, Gayther SA. (2004). A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro. Lab Invest 84: 923-931.
10. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS et al. (1999). Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21: 115-118.
11. Rohrschneider LR, Bourette RP, Lioubin MN, Algate PA, Myles GM, Carlberg K. (1997). Growth and differentiation signals regulated by the M-CSF receptor. Mol Reprod Dev 46: 96-103.
12. Scholl SM, Pallud C, Beuvon F, Hacene K, Stanley ER, Rohrschneider L et al. (1994). Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 86: 120-126.
13. Sherr CJ, Roussel MF, Rettenmier CW. (1988). Colony-stimulating factor-1 receptor (c-fms). J Cell Biochem 38: 179-187.
14. Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH. (1983). CSF-1 - a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 21: 151-159.
15. Tang R, Beuvon F, Ojeda M, Mosseri V, Pouillart P, Scholl S. (1992). M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J Cell Biochem 50: 350-356.
16. Urban S, Freeman M. (2002). Intramembrane proteolysis controls diverse signalling pathways throughout evolution. Curr Opin Genet Dev 12: 512-518.
17. Whitaker NJ, Bryan TM, Bonnefin P, Chang AC, Musgrove EA, Braithwaite AW et al. (1995). Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells. Oncogene 11: 971-976.
18. Yang G, Rosen DG, Colacino JA, Mercado-Uribe I, Liu J. (2006). Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells. Oncogene 26: 1492-1498.